443 related articles for article (PubMed ID: 32888943)
1. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
[TBL] [Abstract][Full Text] [Related]
2. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders.
Montaut S; Tranchant C; Drouot N; Rudolf G; Guissart C; Tarabeux J; Stemmelen T; Velt A; Fourrage C; Nitschké P; Gerard B; Mandel JL; Koenig M; Chelly J; Anheim M;
JAMA Neurol; 2018 Oct; 75(10):1234-1245. PubMed ID: 29913018
[TBL] [Abstract][Full Text] [Related]
4. Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected Findings.
Rudilla F; Franco-Jarava C; Martínez-Gallo M; Garcia-Prat M; Martín-Nalda A; Rivière J; Aguiló-Cucurull A; Mongay L; Vidal F; Solanich X; Irastorza I; Santos-Pérez JL; Tercedor Sánchez J; Cuscó I; Serra C; Baz-Redón N; Fernández-Cancio M; Carreras C; Vagace JM; Garcia-Patos V; Pujol-Borrell R; Soler-Palacín P; Colobran R
Front Immunol; 2019; 10():2325. PubMed ID: 31681265
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Whole Exome Sequencing and Targeted Panels for the Identification of Inborn Errors of Immunity in a Resource-Constrained Setting.
Engelbrecht C; Urban M; Schoeman M; Paarwater B; van Coller A; Abraham DR; Cornelissen H; Glashoff R; Esser M; Möller M; Kinnear C; Glanzmann B
Front Immunol; 2021; 12():665621. PubMed ID: 34093558
[TBL] [Abstract][Full Text] [Related]
6. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
Front Immunol; 2022; 13():906328. PubMed ID: 35874679
[TBL] [Abstract][Full Text] [Related]
7. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
[TBL] [Abstract][Full Text] [Related]
8. Whole exome sequencing (WES) approach for diagnosing primary immunodeficiencies (PIDs) in a highly consanguineous community.
Simon AJ; Golan AC; Lev A; Stauber T; Barel O; Somekh I; Klein C; AbuZaitun O; Eyal E; Kol N; Unal E; Amariglio N; Rechavi G; Somech R
Clin Immunol; 2020 May; 214():108376. PubMed ID: 32135276
[TBL] [Abstract][Full Text] [Related]
9. Targeted gene panel provides advantages over whole-exome sequencing for diagnosing obesity and diabetes mellitus.
Yu H; Yu H; Zhang R; Peng D; Yan D; Gu Y; Bao Y; Jia W; Zhang H; Hu C
J Mol Cell Biol; 2023 Nov; 15(6):. PubMed ID: 37327085
[TBL] [Abstract][Full Text] [Related]
10. Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing.
Arunachalam AK; Maddali M; Aboobacker FN; Korula A; George B; Mathews V; Edison ES
J Clin Immunol; 2021 Feb; 41(2):393-413. PubMed ID: 33225392
[TBL] [Abstract][Full Text] [Related]
11. Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies.
Cifaldi C; Brigida I; Barzaghi F; Zoccolillo M; Ferradini V; Petricone D; Cicalese MP; Lazarevic D; Cittaro D; Omrani M; Attardi E; Conti F; Scarselli A; Chiriaco M; Di Cesare S; Licciardi F; Davide M; Ferrua F; Canessa C; Pignata C; Giliani S; Ferrari S; Fousteri G; Barera G; Merli P; Palma P; Cesaro S; Gattorno M; Trizzino A; Moschese V; Chini L; Villa A; Azzari C; Finocchi A; Locatelli F; Rossi P; Sangiuolo F; Aiuti A; Cancrini C; Di Matteo G
Front Immunol; 2019; 10():316. PubMed ID: 31031743
[No Abstract] [Full Text] [Related]
12. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
13. A 2020 update on the use of genetic testing for patients with primary immunodeficiency.
Chinn IK; Orange JS
Expert Rev Clin Immunol; 2020 Sep; 16(9):897-909. PubMed ID: 32822560
[TBL] [Abstract][Full Text] [Related]
14. Coverage and diagnostic yield of Whole Exome Sequencing for the Evaluation of Cases with Dilated and Hypertrophic Cardiomyopathy.
Mak TSH; Lee YK; Tang CS; Hai JSH; Ran X; Sham PC; Tse HF
Sci Rep; 2018 Jul; 8(1):10846. PubMed ID: 30022097
[TBL] [Abstract][Full Text] [Related]
15. The utility of next-generation sequencing technologies in diagnosis of Mendelian mitochondrial diseases and reflections on clinical spectrum.
Kose M; Isik E; Aykut A; Durmaz A; Kose E; Ersoy M; Diniz G; Adebali O; Ünalp A; Yilmaz Ü; Karaoğlu P; Edizer S; Tekin HG; Özdemir TR; Atik T; Onay H; Özkınay F
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):417-430. PubMed ID: 33629572
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Whole-Exome Sequencing for the Identification of Causal Mutations in Patients with Suspected Inherited Ocular Diseases.
Ordoñez-Labastida V; Montes-Almanza L; García-Martínez F; Zenteno JC
Rev Invest Clin; 2022; 74(4):219-226. PubMed ID: 36087940
[TBL] [Abstract][Full Text] [Related]
17. A semiautomated whole-exome sequencing workflow leads to increased diagnostic yield and identification of novel candidate variants.
Ji J; Shen L; Bootwalla M; Quindipan C; Tatarinova T; Maglinte DT; Buckley J; Raca G; Saitta SC; Biegel JA; Gai X
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30755392
[TBL] [Abstract][Full Text] [Related]
18. Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study.
Rojas-Restrepo J; Caballero-Oteyza A; Huebscher K; Haberstroh H; Fliegauf M; Keller B; Kobbe R; Warnatz K; Ehl S; Proietti M; Grimbacher B
Front Immunol; 2021; 12():786516. PubMed ID: 34975878
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Yield of Next Generation Sequencing in Genetically Undiagnosed Patients with Primary Immunodeficiencies: a Systematic Review.
Yska HAF; Elsink K; Kuijpers TW; Frederix GWJ; van Gijn ME; van Montfrans JM
J Clin Immunol; 2019 Aug; 39(6):577-591. PubMed ID: 31250335
[TBL] [Abstract][Full Text] [Related]
20. Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic Centers.
Elsink K; Huibers MMH; Hollink IHIM; Simons A; Zonneveld-Huijssoon E; van der Veken LT; Leavis HL; Henriet SSV; van Deuren M; van de Veerdonk FL; Potjewijd J; Berghuis D; Dalm VASH; Vermont CL; van de Ven AAJM; Lambeck AJA; Abbott KM; van Hagen PM; de Bree GJ; Kuijpers TW; Frederix GWJ; van Gijn ME; van Montfrans JM;
Front Immunol; 2021; 12():780134. PubMed ID: 34992599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
